RT Book, Section
A1 Auyang, Edward D.
A1 Oelschlager, Brant K.
A2 Sugarbaker, David J.
A2 Bueno, Raphael
A2 Colson, Yolonda L.
A2 Jaklitsch, Michael T.
A2 Krasna, Mark J.
A2 Mentzer, Steven J.
A2 Williams, Marcia
A2 Adams, Ann
SR Print(0)
ID 1105840255
T1 Surgery and Endoscopic Interventions for Barrett Esophagus
T2 Adult Chest Surgery, 2e
YR 2015
FD 2015
PB McGraw-Hill Education
PP New York, NY
SN 978-0-07-178189-3
LK accesssurgery.mhmedical.com/content.aspx?aid=1105840255
RD 2024/04/20
AB Barrett  esophagus  (BE)  is  a  condition  in  which  the  stratified  squamous  epithelium  of  the  esophagus  is  replaced  by  intestinal  columnar  epithelium,  a  process  called  intestinal  metaplasia  (IM).  Dr.  Norman  Barrett,  an  Australian  thoracic  surgeon,  characterized  the  findings  in  an  article  that  he  published  in  1950.1  In  1953,  the  association  was  made  between  BE  and  gastroesophageal  reflux  disease  (GERD)  by  the  English  thoracic  surgeon  Dr.  Philip  Allison.2  The  etiology  of  BE  is  accepted  to  be  due  to  chronic  exposure  of  the  esophageal  epithelium  to  gastroduodenal  refluxate.  The  importance  of  BE  is  its  potential  to  progress  and  develop  into  adenocarcinoma.  The  association  between  BE  and  esophageal  adenocarcinoma  was  established  in  a  case  report  in  1975  by  Dr.  Alan  Farnsworth,  a  cardiac  surgeon,  in  which  he  identified  adenocarcinoma  in  a  segment  of  BE.3